Robert Lenz

6.0k total citations · 4 hit papers
77 papers, 4.4k citations indexed

About

Robert Lenz is a scholar working on Psychiatry and Mental health, Surgery and Molecular Biology. According to data from OpenAlex, Robert Lenz has authored 77 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Psychiatry and Mental health, 21 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Robert Lenz's work include Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (15 papers) and Nicotinic Acetylcholine Receptors Study (10 papers). Robert Lenz is often cited by papers focused on Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (15 papers) and Nicotinic Acetylcholine Receptors Study (10 papers). Robert Lenz collaborates with scholars based in United States, Germany and United Kingdom. Robert Lenz's co-authors include Daniel D. Mikol, Uwe Reuter, Messoud Ashina, Jan Lewis Brandes, Hernàn Picard, Peter J. Goadsby, Stephen D. Silberstein, Stewart J. Tepper, Bradley E. Alger and Feng Zhang and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and Neurology.

In The Last Decade

Robert Lenz

74 papers receiving 4.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Erenumab for Episodic Migraine

2017 631 citations Peter J. Goadsby, Uwe Reuter et al. profile →
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

2017 538 citations Stewart J. Tepper, Messoud Ashina et al. The Lancet Neurology profile →
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

2013 487 citations Ahmed A. Othman, Weining Robieson et al. The Lancet Neurology profile →
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

2018 423 citations David W. Dodick, Messoud Ashina et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert Lenz	2.8k	2.0k	1.2k	774	663	77	4.4k
Michael Bjørn Russell	4.1k 1.5×	2.1k 1.1×	1.6k 1.4×	529 0.7×	368 0.6×	124	5.4k
Takao Takeshima	1.9k 0.7×	913 0.5×	1.1k 0.9×	704 0.9×	639 1.0×	163	4.4k
Piero Barbanti	2.3k 0.8×	1.3k 0.6×	1.0k 0.9×	816 1.1×	263 0.4×	138	3.5k
Patricia Pozo‐Rosich	4.1k 1.5×	2.3k 1.1×	1.3k 1.1×	1.3k 1.6×	271 0.4×	206	5.2k
Simon Akerman	5.1k 1.8×	2.6k 1.3×	2.2k 1.9×	397 0.5×	693 1.0×	107	6.6k
Philip R. Holland	3.9k 1.4×	1.9k 0.9×	1.7k 1.4×	326 0.4×	401 0.6×	85	5.1k
János Tajti	2.4k 0.8×	1.1k 0.6×	1.2k 1.1×	207 0.3×	875 1.3×	95	3.5k
Sait Ashina	3.6k 1.3×	1.9k 0.9×	1.3k 1.1×	725 0.9×	160 0.2×	111	4.7k
Péter Sándor	2.2k 0.8×	1.2k 0.6×	1.0k 0.9×	315 0.4×	204 0.3×	110	3.4k
Paul L. Durham	2.1k 0.7×	1.3k 0.6×	1.7k 1.5×	533 0.7×	942 1.4×	97	4.3k

Countries citing papers authored by Robert Lenz

Since Specialization

Citations

This map shows the geographic impact of Robert Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lenz more than expected).

Fields of papers citing papers by Robert Lenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lenz. The network helps show where Robert Lenz may publish in the future.

Co-authorship network of co-authors of Robert Lenz

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Lenz. A scholar is included among the top collaborators of Robert Lenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Lenz. Robert Lenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rudolf, Henrik, et al.. (2023). What makes an orthopaedic paper highly citable? A bibliometric analysis of top orthopeadic journals with 10‐year follow up. Journal of Experimental Orthopaedics. 10(1). 78–78. 2 indexed citations

Tischer, Thomas, et al.. (2023). Comparison between dedicated MRI and symphyseal fluoroscopic guided contrast agent injection in the diagnosis of cleft sign in athletic groin pain and association with pelvic ring instability. European Radiology. 33(10). 7321–7329. 1 indexed citations

Blanke, Fabian, et al.. (2020). Predictors for an unsuccessful conservative treatment of patients with medial patellar plica syndrome. Archives of Orthopaedic and Trauma Surgery. 141(1). 93–98. 2 indexed citations

Lenz, Robert, et al.. (2019). Impact of compression stockings on leg swelling after arthroscopy – a prospective randomised pilot study. BMC Musculoskeletal Disorders. 20(1). 161–161. 12 indexed citations

Lenz, Robert, et al.. (2018). Was erwarten Orthopäden und Unfallchirurgen vom Radiologen bei der Beurteilung der Bildgebung des Ellenbogens?. Der Radiologe. 58(11). 968–975. 2 indexed citations

Goadsby, Peter J., Koen Paemeleire, Gregor Broessner, et al.. (2017). Efficacy of erenumab in subjects with episodic migraine with prior preventive treatment failure(s). Ghent University Academic Bibliography (Ghent University). 8 indexed citations

Ashina, Messoud, David W. Dodick, Peter J. Goadsby, et al.. (2017). Erenumab (AMG 334) in episodic migraine. Neurology. 89(12). 1237–1243. 109 indexed citations

Tepper, Stewart J., Messoud Ashina, Uwe Reuter, et al.. (2017). Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet Neurology. 16(6). 425–434. 538 indexed citations breakdown →

Lenz, Robert, David W. Dodick, Peter J. Goadsby, et al.. (2016). Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001). Neurology. 86(16_supplement). 1 indexed citations

10.

Gault, Laura M., Robert Lenz, Craig Ritchie, et al.. (2016). ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension. Alzheimer s Research & Therapy. 8(1). 44–44. 33 indexed citations

11.

Lenz, Robert, Matthias Kieb, Paula Diehl, et al.. (2016). Injektionen an Muskeln, Sehnen und Gelenken. Der Orthopäde. 45(5). 459–468. 4 indexed citations

12.

Haig, George M., Earle Bain, Weining Robieson, et al.. (2014). A Randomized Trial of the Efficacy and Safety of the H3 Antagonist ABT-288 in Cognitive Impairment Associated With Schizophrenia. Schizophrenia Bulletin. 40(6). 1433–1442. 50 indexed citations

13.

Lenz, Robert, Peter Kreuz, & Thomas Tischer. (2014). Arthroskopische Resektion des Akromioklavikulargelenks. Operative Orthopädie und Traumatologie. 26(3). 245–253.

14.

Schulze, Christoph, et al.. (2013). Cell viability, collagen synthesis and cytokine expression in human osteoblasts following incubation with generated wear particles using different bone cements. International Journal of Molecular Medicine. 32(1). 227–234. 14 indexed citations

15.

Lenz, Robert, Jeffrey D. Baker, Charles Locke, et al.. (2011). The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology. 220(1). 97–107. 47 indexed citations

16.

Othman, Ahmed A., et al.. (2010). Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers. The Journal of Clinical Pharmacology. 51(4). 512–526. 20 indexed citations

17.

Lenz, Robert, et al.. (2009). Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study. Pediatric Neurology. 41(2). 101–110. 2 indexed citations

18.

Lenz, Robert, Wolfram Mittelmeier, Doris Hansmann, et al.. (2008). Response of human osteoblasts exposed to wear particles generated at the interface of total hip stems and bone cement. Journal of Biomedical Materials Research Part A. 89A(2). 370–378. 32 indexed citations

19.

Lenz, Robert & Bradley E. Alger. (1999). Calcium dependence of depolarization‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons. The Journal of Physiology. 521(1). 147–157. 50 indexed citations

20.

Benton, Bernard J., et al.. (1993). Central and peripheral cardio-respiratory effects of saxitoxin (STX) in urethane-anesthetized guinea-pigs. Toxicon. 31(5). 645–664. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact